Does DACLIZUMAB Cause Multiple sclerosis relapse? 313 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 313 reports of Multiple sclerosis relapse have been filed in association with DACLIZUMAB. This represents 11.2% of all adverse event reports for DACLIZUMAB.
313
Reports of Multiple sclerosis relapse with DACLIZUMAB
11.2%
of all DACLIZUMAB reports
6
Deaths
230
Hospitalizations
How Dangerous Is Multiple sclerosis relapse From DACLIZUMAB?
Of the 313 reports, 6 (1.9%) resulted in death, 230 (73.5%) required hospitalization, and 2 (0.6%) were considered life-threatening.
Is Multiple sclerosis relapse Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DACLIZUMAB. However, 313 reports have been filed with the FAERS database.
What Other Side Effects Does DACLIZUMAB Cause?
Alopecia (450)
Transplant dysfunction (421)
Transplant rejection (385)
Acne (382)
Ovarian cyst (374)
Drug ineffective (229)
Pain (224)
Pneumonia (213)
Condition aggravated (172)
Liver function test abnormal (159)
What Other Drugs Cause Multiple sclerosis relapse?
DIMETHYL (6,852)
FINGOLIMOD (6,728)
NATALIZUMAB (6,478)
INTERFERON BETA-1A (5,931)
TERIFLUNOMIDE (4,745)
GLATIRAMER (3,695)
DALFAMPRIDINE (3,322)
OCRELIZUMAB (2,326)
OFATUMUMAB (1,525)
INTERFERON BETA-1B (1,229)
Which DACLIZUMAB Alternatives Have Lower Multiple sclerosis relapse Risk?
DACLIZUMAB vs DACOMITINIB
DACLIZUMAB vs DACTINOMYCIN
DACLIZUMAB vs DALBAVANCIN
DACLIZUMAB vs DALFAMPRIDINE
DACLIZUMAB vs DALTEPARIN